Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

Not Applicable

Active, not recruiting

• Conditions: Lung Cancer
• Interventions: Behavioral: Tele-Navi LCS

• Registration Number: NCT05021133
• Lead Sponsor: University of Massachusetts, Worcester

Brief Summary

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-08-10
• Study First Submitted QC: 2021-08-19
• Study First Posted: 2021-08-25
• Study Start: 2023-06-05
• Primary Completion: 2023-08-11
• Results First Submitted: 2024-08-05
• Results First Submitted QC: 2024-08-05
• Results First Posted: 2024-08-29
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-18
• Last Update Posted: 2025-03-26
• Study Completion: 2025-09

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

• Is eligible for LDCT for LCS follow-up
• Has technology to complete study activities (e.g., video call visit)
• English speaker
• Has undergone LCS at UMMH
• Is overdue for LDCT follow-up

Exclusion Criteria

• Has previous diagnosis of lung cancer
• Has active cancer diagnosis
• Is a nursing home or group care resident
• Is pregnant

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Tele-Navi LCS	Tele-Navi LCS	Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS

Primary Outcome Measures

Name	Time	Method
Completion of Tele-Navi LCS	30 days	Number of participants completed Tele-Navi LCS,

Secondary Outcome Measures

Name	Time	Method
Completion of Follow-up LCS	180 days	Number of participants who received a low-dose CT (LDCT) for LCS follow-up

Trial Locations

Locations (1)

UMass Chan Medical School; 🇺🇸 Worcester, Massachusetts, United States